DERMJourney Medical Corp
Earnings
When Journey Medical Corp reports, what it reported each quarter, and how the stock took the results.
25 quarters. Sep 30, 2020 to Sep 30, 2026. USD.
Next results · Q4 2026Projected
Mar 24, after the close
Wed, Mar 24, 2027in 126 days
Projected from its last 8 releases. The company has not named the day yet.
- Quarter
- Q4 2026 · Ends about Dec 31, 2026
- 10-K window
- Mar 23 – Apr 2
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- $16.69M
- Revenue, change from a year earlier: Q3 2026 +11.2%, Q2 2026 +18.9%, Q1 2026 +21.2%, Q4 2025 +22.5%
- Net income
- -$1.25M
- Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
- EPS
- —
- EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m
Latest results
- Revenue
- $18.93M
- +11.2%
- Net income
- -$1.32M
- N/M
- EPS
- -$0.05
- N/M
- Revenue
- $17.84M
- +18.9%
- Net income
- -$312.00K
- N/M
- EPS
- -$0.01
- N/M
- Revenue
- $15.92M
- +21.2%
- Net income
- -$2.23M
- N/M
- EPS
- -$0.08
- N/M
- Revenue
- $16.69M
- +22.5%
- Net income
- -$1.25M
- N/M
- EPS
- —
- —
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | Nov 12, 2026 · after-hours | Nov 12, 2026 | 43 d | 10-Q | $18.93M | +11.2% | -$0.05 | — | |
| Q2 2026 | Jun 30, 2026 | Aug 12, 2026 · after-hours | Aug 12, 2026 | 43 d | 10-Q | $17.84M | +18.9% | -$0.01 | +3.8% | |
| Q1 2026 | Mar 31, 2026 | May 13, 2026 · after-hours | May 13, 2026 | 43 d | 10-Q | $15.92M | +21.2% | -$0.08 | +23.1% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | Mar 25, 2026 · after-hours | Mar 26, 2026 | 85 d | 10-K | $16.69M | +22.5% | — | 30.1% | |
| Q3 2025 | Sep 30, 2025 | Nov 12, 2025 · after-hours | Nov 12, 2025 | 43 d | 10-Q | $17.03M | +16.4% | -$0.09 | 15.1% | |
| Q2 2025 | Jun 30, 2025 | Aug 12, 2025 · after-hours | Aug 12, 2025 | 43 d | 10-Q | $15.01M | +1.0% | -$0.16 | 14.7% | |
| Q1 2025 | Mar 31, 2025 | May 14, 2025 · after-hours | May 15, 2025 | 45 d | 10-Q | $13.14M | +0.8% | -$0.18 | +17.4% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | Mar 26, 2025 · after-hours | Mar 27, 2025 | 86 d | 10-K | $13.62M | −10.7% | — | 3.6% | |
| Q3 2024 | Sep 30, 2024 | Nov 12, 2024 · after-hours | Nov 12, 2024 | 43 d | 10-Q | $14.63M | −4.3% | -$0.12 | 4.4% | |
| Q2 2024 | Jun 30, 2024 | Aug 12, 2024 · after-hours | Aug 13, 2024 | 44 d | 10-Q | $14.86M | −12.4% | -$0.17 | 4.4% | |
| Q1 2024 | Mar 31, 2024 | May 13, 2024 · after-hours | May 14, 2024 | 44 d | 10-Q | $13.03M | +7.1% | -$0.53 | +1.1% | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | Mar 21, 2024 · after-hours | Mar 29, 2024 | 89 d | 10-K | $15.26M | −4.2% | — | 13.6% | |
| Q3 2023 | Sep 30, 2023 | Nov 7, 2023 · after-hours | Nov 13, 2023 | 44 d | 10-Q | $15.28M | −4.8% | $0.80 | — | |
| Q2 2023 | Jun 30, 2023 | Aug 8, 2023 · after-hours | Aug 10, 2023 | 41 d | 10-Q | $16.96M | −7.0% | -$0.46 | 6.7% | |
| Q1 2023 | Mar 31, 2023 | May 22, 2023 · after-hours | May 22, 2023 | 52 d | 10-Q | $12.17M | −41.5% | -$0.57 | — | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | Mar 29, 2023 · after-hours | Mar 31, 2023 | 90 d | 10-K | $15.92M | −9.1% | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 10, 2022 · after-hours | Nov 10, 2022 | 41 d | 10-Q | $16.04M | −18.2% | -$0.57 | — | |
| Q2 2022 | Jun 30, 2022 | Aug 9, 2022 · after-hours | Aug 9, 2022 | 40 d | 10-Q | $18.24M | +19.3% | -$0.43 | — | |
| Q1 2022 | Mar 31, 2022 | May 10, 2022 · after-hours | May 10, 2022 | 40 d | 10-Q | $20.80M | +94.0% | -$0.08 | — | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | Mar 23, 2022 · after-hours | Mar 28, 2022 | 87 d | 10-K | $17.52M | — | — | — | |
| Q3 2021 | Sep 30, 2021 | Dec 10, 2021 · after-hours | Dec 16, 2021 | 77 d | 10-Q | $19.61M | +107.6% | -$1.16 | 5.3% | |
| Q2 2021 | Jun 30, 2021 | — | — | — | — | $15.29M | — | -$1.30 | — | |
| Q1 2021 | Mar 31, 2021 | — | — | — | — | $10.72M | — | $0.02 | — | |
| FY 2020 | ||||||||||
| Q4 2020derived | Dec 31, 2020 | — | — | — | — | — | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | $9.45M | — | $0.00 | — | |
Earlier years, FY 2020 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Journey Medical Corp · CIK 1867066 · Engraved from SEC EDGAR